Device manufacturers whose establishments have been audited under one of the regulatory systems of a founding member of the Global Harmonization Task Force might be able to avoid undergoing a re-inspection by the US Food and Drug Administration for a period of one year1,2...
Scrip Regulatory Affairs
US proposes to skip inspection of firms audited by a GHTF member
24 May 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Swedish objection letter criticises medtech quality system standard
- Canada consults on plans to schedule device company inspections based on risk
- Singapore plans to introduce new framework for medtech trials in 2012
- EU IVD voice calls for authorities to recognise ISO 13485 QMS standard or offer solutions
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
